结核病的病原体特异性药物代谢:酶,代谢途径,以及治疗开发的新视野
Periyasamy Vijayalakshmi1, Faiz Alfaiz2, Rajendran Vijayakumar2
1PG and Research Department of Biotechnology and Bioinformatics, Holy Cross College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
Microbial pathogenesis
|November 12, 2025
概括
结核病 (TB) 治疗受到药物耐药性的挑战. 结核菌 (Mtb) 直接代谢药物,影响药物的疗效和耐药性. 了解 Mtb 的理解
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
背景情况:
- 结核病 (TB) 构成了重大的全球卫生挑战,因药物耐药性增加而加剧.
- 现有的抗结核药物主要向宿主生物化学途径,药物代谢发生在肝脏中.
- 新兴证据显示,结核菌 (Mtb) 活跃参与药物生物转化,影响治疗结果.
研究的目的:
- 探索Mtb介导的药物生物转化机制和酶.
- 为了比较基于宿主和基于病原体的药物代谢模型.
- 确定针对Mtb代谢活动的新型治疗策略.
主要方法:
- 对Mtb介导药物代谢途径和酶的审查.
- 静态肝脏模型与动态病原体模型的比较分析.
- 探索Mtb对药物药理动力学和生物可用性的影响.
- 讨论用于Mtb药物代谢研究的有机体和机器学习等先进模型.
主要成果:
- Mtb通过其酶和代谢途径直接改变抗结核剂.
- 宿主和病原体的新陈代谢共同决定药物的有效性和耐药性.
- Mtb驱动的生物转化显著影响药物的半衰期和生物可用性.
- 先进的模型为Mtb药物代谢提供了更深入的见解.
结论:
- 针对MTB特定的酶和通路对于开发新的抗结核药物至关重要.
- 组合疗法和宿主导疗法 (HDT) 是有前途的.
- 考虑到Mtb代谢的精准医学方法对于有效的结核病治疗至关重要.
相关概念视频
Pulmonary Tuberculosis V
530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Pulmonary Tuberculosis I
816
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
816
Pharmacokinetics in Pediatric Patients: Drug Metabolism
182
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
698
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
698
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Drug Biotransformation: Overview
2.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.4K


